| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
77,724 |
71,179 |
$34.21M |
| 0450 |
Emergency room services |
110,845 |
100,176 |
$31.89M |
| 99499 |
|
53,161 |
42,400 |
$13.94M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
18,424 |
17,967 |
$12.41M |
| 99199 |
Unlisted special service, procedure or report |
11,446 |
8,614 |
$7.69M |
| 80053 |
Comprehensive metabolic panel |
171,205 |
153,027 |
$6.89M |
| 70450 |
Computed tomography, head or brain; without contrast material |
22,906 |
22,029 |
$5.70M |
| 0762 |
|
11,662 |
5,867 |
$5.60M |
| 0360 |
|
5,991 |
3,167 |
$4.99M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
74,849 |
66,487 |
$4.27M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
14,500 |
13,033 |
$4.19M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
11,282 |
10,186 |
$4.09M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
187,789 |
163,953 |
$3.38M |
| 0121 |
|
446 |
423 |
$3.33M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
6,455 |
6,303 |
$2.61M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
35,135 |
32,516 |
$2.60M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
33,131 |
28,707 |
$2.55M |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
2,952 |
2,903 |
$2.28M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
22,550 |
20,554 |
$2.25M |
| 71046 |
Radiologic examination, chest; 2 views |
39,733 |
38,125 |
$2.13M |
| 0206 |
|
215 |
205 |
$1.87M |
| 0160 |
|
2,745 |
1,353 |
$1.82M |
| 95811 |
|
2,662 |
2,628 |
$1.81M |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
3,684 |
3,574 |
$1.64M |
| 84484 |
|
54,449 |
48,537 |
$1.50M |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
12,185 |
5,776 |
$1.40M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
25,156 |
22,731 |
$1.39M |
| 59025 |
Fetal non-stress test |
9,583 |
3,334 |
$1.36M |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
34,380 |
31,588 |
$1.35M |
| 71045 |
Radiologic examination, chest; single view |
32,149 |
30,240 |
$1.33M |
| 76801 |
|
9,111 |
8,149 |
$1.33M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
1,847 |
1,821 |
$1.30M |
| 0519 |
|
16,636 |
15,253 |
$1.17M |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
7,064 |
6,893 |
$1.12M |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
10,837 |
10,391 |
$1.10M |
| Z7502 |
|
30,161 |
29,921 |
$1.10M |
| 97139 |
|
34,620 |
9,693 |
$1.09M |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,675 |
3,609 |
$1.07M |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
27,948 |
27,196 |
$1.04M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
3,311 |
3,165 |
$1.03M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,981 |
1,928 |
$960K |
| 81001 |
|
68,639 |
64,940 |
$945K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
2,648 |
2,611 |
$940K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
8,756 |
7,761 |
$940K |
| 83690 |
|
43,398 |
40,797 |
$900K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
9,444 |
6,496 |
$882K |
| 82962 |
|
46,636 |
35,897 |
$799K |
| 70486 |
|
2,389 |
2,357 |
$799K |
| 93971 |
|
4,796 |
4,655 |
$778K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
7,906 |
7,605 |
$744K |
| 0300 |
|
818 |
751 |
$717K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
2,398 |
2,329 |
$683K |
| 0710 |
|
3,578 |
3,472 |
$671K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
5,331 |
5,250 |
$669K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
6,602 |
5,859 |
$627K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
5,418 |
5,271 |
$619K |
| 76830 |
Ultrasound, transvaginal |
4,857 |
4,742 |
$617K |
| 93970 |
|
2,928 |
2,843 |
$604K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
5,638 |
5,158 |
$560K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
23,365 |
22,403 |
$557K |
| 82077 |
|
15,232 |
14,021 |
$535K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
20,547 |
6,221 |
$514K |
| 71250 |
|
2,391 |
2,355 |
$509K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
16,883 |
14,819 |
$508K |
| 87040 |
|
7,170 |
6,789 |
$505K |
| 72100 |
|
8,538 |
8,409 |
$492K |
| 99219 |
|
766 |
320 |
$484K |
| 0721 |
|
7,672 |
6,021 |
$475K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
7,914 |
5,574 |
$466K |
| 76770 |
|
5,578 |
5,463 |
$454K |
| 73562 |
|
8,883 |
7,780 |
$453K |
| 73630 |
|
7,752 |
7,157 |
$443K |
| 97799 |
|
13,599 |
2,994 |
$434K |
| 73030 |
|
6,953 |
6,445 |
$429K |
| 0250 |
|
6,075 |
4,456 |
$404K |
| 70491 |
|
1,130 |
1,093 |
$403K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
23,312 |
8,239 |
$397K |
| 84703 |
|
28,344 |
26,532 |
$393K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
14,171 |
13,574 |
$373K |
| G0378 |
Hospital observation service, per hour |
2,218 |
1,882 |
$366K |
| 84702 |
|
9,423 |
8,334 |
$363K |
| 74178 |
|
649 |
642 |
$360K |
| 73610 |
|
5,694 |
5,352 |
$357K |
| 73130 |
|
5,643 |
5,107 |
$331K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
7,434 |
7,249 |
$327K |
| 83735 |
|
20,546 |
18,065 |
$323K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
926 |
869 |
$316K |
| 83880 |
|
13,574 |
12,770 |
$315K |
| 85610 |
|
22,549 |
20,523 |
$302K |
| 76813 |
|
3,539 |
3,496 |
$292K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
7,399 |
7,028 |
$289K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,220 |
1,998 |
$289K |
| Z9725 |
|
6,432 |
6,418 |
$277K |
| 72040 |
|
4,383 |
4,292 |
$275K |
| 70498 |
|
594 |
587 |
$274K |
| 93976 |
|
1,588 |
1,542 |
$272K |
| 0760 |
|
4,742 |
4,328 |
$256K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
2,331 |
2,306 |
$256K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
2,571 |
2,527 |
$251K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12,824 |
12,494 |
$244K |
| 97161 |
|
4,795 |
4,553 |
$243K |
| 80143 |
|
5,934 |
5,518 |
$225K |
| 70496 |
|
532 |
528 |
$218K |
| 73700 |
|
1,100 |
1,071 |
$217K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,268 |
1,222 |
$217K |
| 80179 |
|
5,843 |
5,442 |
$213K |
| 73110 |
|
3,608 |
3,366 |
$210K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
7,530 |
7,347 |
$203K |
| 76870 |
|
1,454 |
1,413 |
$201K |
| 84443 |
Thyroid stimulating hormone (TSH) |
14,395 |
13,896 |
$198K |
| J3490 |
Unclassified drugs |
5,372 |
3,833 |
$193K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
711 |
695 |
$190K |
| 0410 |
|
251 |
237 |
$190K |
| 76536 |
|
1,902 |
1,866 |
$189K |
| 85730 |
|
17,048 |
16,132 |
$187K |
| 77336 |
|
2,040 |
901 |
$183K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,682 |
4,481 |
$181K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,254 |
7,807 |
$179K |
| 87081 |
|
8,501 |
8,312 |
$179K |
| 93017 |
|
1,182 |
1,114 |
$177K |
| J2785 |
Injection, regadenoson, 0.1 mg |
702 |
649 |
$176K |
| 85379 |
|
7,066 |
6,819 |
$171K |
| 0270 |
|
1,489 |
1,271 |
$159K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,491 |
1,663 |
$157K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,241 |
713 |
$155K |
| 77386 |
|
151 |
12 |
$153K |
| 82550 |
|
8,821 |
8,137 |
$147K |
| 73080 |
|
2,371 |
2,258 |
$141K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,461 |
1,260 |
$138K |
| 73502 |
|
3,613 |
3,241 |
$137K |
| 83605 |
|
9,875 |
9,276 |
$136K |
| 86900 |
|
6,077 |
5,735 |
$134K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
727 |
652 |
$133K |
| 71101 |
|
1,822 |
1,776 |
$130K |
| 72072 |
|
1,976 |
1,951 |
$122K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
949 |
860 |
$116K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
5,668 |
2,085 |
$116K |
| 77412 |
|
1,059 |
107 |
$115K |
| 0352 |
|
163 |
158 |
$110K |
| 70480 |
|
367 |
364 |
$108K |
| 86901 |
|
6,067 |
5,726 |
$104K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
436 |
417 |
$104K |
| 81003 |
|
11,737 |
11,287 |
$103K |
| 76820 |
|
2,075 |
1,535 |
$100K |
| Z7500 |
|
2,974 |
2,795 |
$100K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
910 |
845 |
$98K |
| 73590 |
|
2,119 |
1,977 |
$98K |
| 0258 |
|
6,720 |
5,718 |
$96K |
| 93880 |
|
1,017 |
976 |
$95K |
| 0489 |
|
151 |
149 |
$94K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
3,005 |
2,385 |
$93K |
| 12001 |
|
982 |
966 |
$91K |
| 74018 |
|
2,760 |
2,662 |
$89K |
| 77334 |
|
228 |
168 |
$87K |
| 59425 |
|
1,583 |
989 |
$86K |
| 70544 |
|
411 |
397 |
$85K |
| 97162 |
|
3,932 |
3,802 |
$84K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,184 |
2,818 |
$83K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
247 |
241 |
$82K |
| 0761 |
|
2,141 |
1,808 |
$79K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,796 |
5,139 |
$78K |
| 0351 |
|
174 |
168 |
$77K |
| 87510 |
|
5,294 |
5,159 |
$77K |
| 87480 |
|
5,328 |
5,193 |
$76K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
9,694 |
1,551 |
$76K |
| 87660 |
|
5,328 |
5,193 |
$75K |
| 97116 |
|
5,659 |
2,439 |
$74K |
| 71271 |
|
389 |
389 |
$74K |
| 36415 |
Collection of venous blood by venipuncture |
29,672 |
23,932 |
$69K |
| 90715 |
|
3,587 |
3,535 |
$68K |
| 80061 |
Lipid panel |
9,119 |
8,792 |
$62K |
| 94799 |
|
2,379 |
2,171 |
$62K |
| 97014 |
|
5,554 |
1,881 |
$62K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
28,823 |
27,167 |
$62K |
| 0730 |
|
578 |
542 |
$59K |
| 96376 |
|
2,152 |
1,979 |
$59K |
| 73140 |
|
1,427 |
1,366 |
$59K |
| 0324 |
|
619 |
582 |
$59K |
| 72110 |
|
811 |
798 |
$59K |
| 87186 |
|
5,596 |
5,425 |
$55K |
| 73090 |
|
1,104 |
1,058 |
$53K |
| 0272 |
|
407 |
366 |
$51K |
| 84100 |
|
4,481 |
3,761 |
$50K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
3,234 |
1,734 |
$50K |
| 93325 |
|
511 |
506 |
$50K |
| 0402 |
|
204 |
199 |
$49K |
| 93458 |
|
42 |
42 |
$49K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
10,040 |
9,675 |
$48K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,916 |
3,765 |
$47K |
| 87631 |
|
1,435 |
1,382 |
$47K |
| 29125 |
|
837 |
801 |
$47K |
| 86850 |
|
2,347 |
2,190 |
$47K |
| 10060 |
|
477 |
469 |
$44K |
| 87077 |
|
6,304 |
6,101 |
$43K |
| 87641 |
|
2,390 |
2,191 |
$41K |
| 73560 |
|
1,244 |
1,037 |
$41K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
10,161 |
9,153 |
$41K |
| 86140 |
|
4,233 |
3,995 |
$41K |
| 85027 |
|
4,405 |
4,184 |
$40K |
| 0420 |
|
358 |
336 |
$39K |
| 84439 |
|
5,215 |
5,023 |
$38K |
| 77300 |
|
197 |
192 |
$37K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
9,224 |
8,852 |
$35K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
317 |
294 |
$34K |
| 74022 |
|
534 |
530 |
$34K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
6,351 |
5,544 |
$34K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,666 |
1,563 |
$33K |
| C1776 |
Joint device (implantable) |
29 |
29 |
$32K |
| 74221 |
|
336 |
333 |
$32K |
| 75574 |
|
85 |
84 |
$31K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
132 |
120 |
$31K |
| 80164 |
|
2,218 |
1,942 |
$31K |
| 84145 |
|
1,922 |
1,750 |
$31K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,906 |
8,515 |
$30K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
268 |
254 |
$28K |
| 80047 |
|
1,236 |
1,184 |
$27K |
| 10005 |
|
110 |
110 |
$27K |
| 72141 |
|
77 |
75 |
$26K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,934 |
2,487 |
$26K |
| H1003 |
Prenatal care, at-risk enhanced service; education |
1,998 |
1,178 |
$26K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,737 |
3,654 |
$25K |
| 87070 |
|
2,348 |
2,258 |
$25K |
| 72050 |
|
342 |
337 |
$24K |
| 19083 |
|
34 |
28 |
$23K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
111 |
110 |
$23K |
| 95808 |
|
59 |
59 |
$22K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
6,936 |
6,112 |
$22K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
22,477 |
20,401 |
$21K |
| 76825 |
|
115 |
114 |
$21K |
| 72170 |
|
383 |
379 |
$21K |
| 62323 |
|
196 |
189 |
$20K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
115 |
108 |
$19K |
| J2704 |
Injection, propofol, 10 mg |
4,818 |
4,635 |
$19K |
| 97166 |
|
812 |
780 |
$18K |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
449 |
440 |
$18K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,494 |
1,396 |
$18K |
| 74183 |
|
65 |
65 |
$18K |
| 73552 |
|
496 |
472 |
$18K |
| 83615 |
|
1,566 |
1,449 |
$18K |
| 99401 |
|
1,743 |
1,063 |
$17K |
| 0320 |
|
132 |
129 |
$17K |
| 82009 |
|
2,546 |
2,402 |
$17K |
| J1953 |
Injection, levetiracetam, 10 mg |
477 |
411 |
$17K |
| 74174 |
|
39 |
38 |
$17K |
| 84550 |
|
2,849 |
2,686 |
$17K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
2,274 |
1,569 |
$16K |
| 87807 |
|
439 |
409 |
$16K |
| 74220 |
|
222 |
214 |
$16K |
| 97803 |
|
329 |
290 |
$16K |
| G0379 |
Direct admission of patient for hospital observation care |
29 |
16 |
$16K |
| 73620 |
|
386 |
312 |
$15K |
| 85652 |
|
3,196 |
3,049 |
$15K |
| 73060 |
|
413 |
393 |
$14K |
| 12002 |
|
161 |
160 |
$14K |
| 70487 |
|
31 |
29 |
$14K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,201 |
1,180 |
$14K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
7,499 |
6,952 |
$14K |
| 97035 |
|
1,121 |
455 |
$14K |
| 82728 |
|
2,793 |
2,706 |
$14K |
| 85384 |
|
580 |
546 |
$13K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,264 |
3,215 |
$13K |
| 97802 |
|
1,088 |
829 |
$12K |
| 82248 |
|
2,811 |
2,758 |
$12K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
657 |
631 |
$12K |
| 82570 |
|
3,374 |
3,212 |
$12K |
| 94660 |
|
80 |
50 |
$12K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
8,816 |
7,998 |
$11K |
| 82553 |
|
396 |
307 |
$11K |
| 97165 |
|
238 |
226 |
$11K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
434 |
431 |
$11K |
| 80178 |
|
661 |
575 |
$11K |
| 86923 |
|
175 |
154 |
$11K |
| J1815 |
Injection, insulin, per 5 units |
1,192 |
804 |
$10K |
| 81025 |
|
2,825 |
2,706 |
$10K |
| J2060 |
Injection, lorazepam, 2 mg |
5,589 |
4,737 |
$10K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,152 |
880 |
$10K |
| 97163 |
|
193 |
190 |
$10K |
| 87427 |
|
353 |
338 |
$10K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
7,604 |
7,192 |
$10K |
| 86308 |
|
474 |
463 |
$10K |
| 76827 |
|
114 |
113 |
$10K |
| 82140 |
|
955 |
851 |
$9K |
| 64483 |
|
30 |
30 |
$9K |
| 82805 |
|
235 |
213 |
$9K |
| 73660 |
|
203 |
197 |
$9K |
| 88304 |
|
317 |
309 |
$9K |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
1,609 |
1,444 |
$9K |
| 12011 |
|
141 |
138 |
$9K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
120 |
97 |
$8K |
| 87045 |
|
454 |
435 |
$8K |
| 97172 |
|
133 |
122 |
$8K |
| 83540 |
|
3,016 |
2,918 |
$8K |
| 87205 |
|
2,088 |
1,987 |
$8K |
| 30520 |
|
25 |
25 |
$8K |
| 85014 |
|
1,275 |
1,220 |
$8K |
| 97010 |
|
796 |
480 |
$8K |
| 0370 |
|
550 |
544 |
$8K |
| 71020 |
|
234 |
123 |
$7K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
38 |
38 |
$7K |
| 83550 |
|
2,690 |
2,599 |
$7K |
| 0002A |
|
193 |
193 |
$7K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
3,022 |
2,642 |
$7K |
| 82731 |
|
68 |
66 |
$7K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
28 |
24 |
$7K |
| J1630 |
Injection, haloperidol, up to 5 mg |
2,793 |
2,427 |
$6K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
6,301 |
5,940 |
$6K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
848 |
732 |
$6K |
| 76882 |
|
126 |
121 |
$6K |
| 87046 |
|
455 |
436 |
$5K |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,244 |
930 |
$5K |
| 93923 |
|
96 |
95 |
$5K |
| A6211 |
Foam dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing |
127 |
75 |
$5K |
| 76942 |
|
69 |
67 |
$5K |
| 0001A |
|
150 |
150 |
$5K |
| 73564 |
|
67 |
61 |
$5K |
| 97535 |
Self-care/home management training, each 15 minutes |
611 |
291 |
$5K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
29 |
25 |
$5K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
605 |
549 |
$5K |
| 88342 |
|
233 |
217 |
$5K |
| 30140 |
|
15 |
15 |
$5K |
| 88307 |
|
70 |
66 |
$5K |
| 0301 |
|
190 |
185 |
$5K |
| 82607 |
|
1,664 |
1,631 |
$5K |
| 87340 |
|
707 |
697 |
$4K |
| 99222 |
Initial hospital care, per day, moderate complexity |
20 |
12 |
$4K |
| 85670 |
|
177 |
161 |
$4K |
| 87653 |
|
271 |
267 |
$4K |
| 96367 |
|
120 |
107 |
$4K |
| C1769 |
Guide wire |
186 |
176 |
$4K |
| 0004A |
|
121 |
114 |
$4K |
| 87449 |
|
512 |
476 |
$4K |
| Q3014 |
Telehealth originating site facility fee |
255 |
233 |
$4K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
255 |
213 |
$4K |
| 74230 |
|
63 |
63 |
$4K |
| 96156 |
|
360 |
284 |
$3K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
1,101 |
1,066 |
$3K |
| 97012 |
|
322 |
129 |
$3K |
| 92611 |
|
85 |
83 |
$3K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
599 |
592 |
$3K |
| 84153 |
|
1,106 |
1,085 |
$3K |
| 86780 |
|
723 |
718 |
$3K |
| 73120 |
|
65 |
52 |
$3K |
| 43235 |
|
24 |
24 |
$3K |
| 95816 |
|
20 |
14 |
$3K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,814 |
1,672 |
$3K |
| 29130 |
|
52 |
50 |
$3K |
| 73221 |
|
16 |
13 |
$2K |
| 92610 |
|
74 |
62 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
796 |
715 |
$2K |
| Z7610 |
|
508 |
320 |
$2K |
| 0430 |
|
68 |
63 |
$2K |
| J1940 |
Injection, furosemide, up to 20 mg |
603 |
444 |
$2K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
45 |
13 |
$2K |
| A4565 |
Slings |
201 |
185 |
$2K |
| 92523 |
|
38 |
38 |
$2K |
| 86803 |
|
306 |
304 |
$2K |
| 71010 |
|
79 |
38 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
29 |
28 |
$2K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
500 |
154 |
$2K |
| 86480 |
|
241 |
241 |
$2K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
200 |
131 |
$2K |
| 73070 |
|
41 |
38 |
$2K |
| 27447 |
|
13 |
13 |
$2K |
| 72220 |
|
25 |
24 |
$2K |
| 82746 |
|
662 |
655 |
$2K |
| 29515 |
|
28 |
27 |
$2K |
| Q4051 |
Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) |
30 |
28 |
$1K |
| 99221 |
|
97 |
90 |
$1K |
| 86762 |
|
209 |
206 |
$1K |
| 83970 |
|
438 |
431 |
$1K |
| 93922 |
|
27 |
27 |
$1K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
27 |
27 |
$1K |
| 87899 |
|
51 |
43 |
$1K |
| 87147 |
|
202 |
193 |
$1K |
| 99234 |
|
66 |
58 |
$1K |
| 76642 |
|
15 |
12 |
$1K |
| 76857 |
|
12 |
12 |
$1K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,013 |
957 |
$1K |
| 82150 |
|
74 |
71 |
$1K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
1,196 |
1,151 |
$1K |
| 72070 |
|
13 |
13 |
$1K |
| 97597 |
|
25 |
12 |
$989.08 |
| 0274 |
|
18 |
18 |
$975.51 |
| 80185 |
|
75 |
57 |
$955.80 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
29 |
28 |
$951.67 |
| 95992 |
|
72 |
54 |
$942.24 |
| J3411 |
Injection, thiamine hcl, 100 mg |
162 |
116 |
$921.17 |
| 87075 |
|
178 |
174 |
$919.32 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
87 |
55 |
$906.50 |
| 82951 |
|
42 |
42 |
$873.35 |
| 0440 |
|
15 |
12 |
$852.25 |
| 82043 |
|
1,825 |
1,799 |
$843.52 |
| 80074 |
|
28 |
28 |
$827.16 |
| 88173 |
|
67 |
67 |
$772.87 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
52 |
51 |
$763.21 |
| 87324 |
|
105 |
99 |
$757.78 |
| 70360 |
|
13 |
13 |
$702.16 |
| 86038 |
|
288 |
283 |
$658.16 |
| A6210 |
Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing |
104 |
71 |
$634.84 |
| 90732 |
|
26 |
24 |
$623.56 |
| 85347 |
|
65 |
61 |
$619.29 |
| 87634 |
|
13 |
13 |
$603.99 |
| 87640 |
|
83 |
83 |
$583.56 |
| 86141 |
|
89 |
88 |
$548.12 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
15 |
14 |
$495.52 |
| 74019 |
|
12 |
12 |
$452.14 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
98 |
95 |
$450.88 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
218 |
213 |
$444.41 |
| 82803 |
|
15 |
15 |
$442.08 |
| 97022 |
|
21 |
12 |
$438.12 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
64 |
13 |
$430.10 |
| C9113 |
Injection, pantoprazole sodium, per vial |
98 |
65 |
$424.13 |
| 80076 |
|
70 |
69 |
$366.91 |
| 82378 |
|
166 |
158 |
$339.40 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
21 |
12 |
$335.49 |
| S9999 |
Sales tax |
21 |
20 |
$304.50 |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
17 |
12 |
$297.60 |
| 88300 |
|
26 |
24 |
$270.40 |
| 90686 |
|
44 |
42 |
$253.89 |
| 85018 |
|
172 |
139 |
$243.64 |
| J3360 |
Injection, diazepam, up to 5 mg |
14 |
13 |
$241.22 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
151 |
146 |
$221.92 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
20 |
15 |
$220.18 |
| 90674 |
|
46 |
46 |
$220.16 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
24 |
24 |
$184.75 |
| J3105 |
Injection, terbutaline sulfate, up to 1 mg |
89 |
83 |
$167.54 |
| 86787 |
|
49 |
49 |
$157.11 |
| 86039 |
|
16 |
15 |
$144.49 |
| 96150 |
|
17 |
14 |
$133.84 |
| 90662 |
|
37 |
37 |
$124.95 |
| J3480 |
Injection, potassium chloride, per 2 meq |
44 |
29 |
$124.36 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
40 |
37 |
$118.96 |
| 82565 |
|
40 |
40 |
$118.38 |
| 86200 |
|
59 |
56 |
$107.18 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
27 |
26 |
$89.80 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
110 |
69 |
$86.09 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
326 |
288 |
$71.80 |
| 80069 |
|
47 |
46 |
$70.94 |
| 81015 |
|
13 |
12 |
$61.75 |
| 86430 |
|
41 |
41 |
$50.18 |
| 84480 |
|
13 |
13 |
$45.02 |
| 83021 |
|
12 |
12 |
$18.44 |
| J7050 |
Infusion, normal saline solution, 250 cc |
13 |
12 |
$9.98 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
25 |
25 |
$1.33 |
| 91300 |
|
283 |
266 |
$0.02 |
| 91307 |
|
38 |
34 |
$0.01 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
174 |
172 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
26 |
26 |
$0.00 |
| 90832 |
Psychotherapy, 30 minutes with patient |
211 |
62 |
$0.00 |